Qingyuan Zhang | Medical Oncology | Best Researcher Award

Posted on by ScienceFather

Prof. Qingyuan Zhang | Medical Oncology | Best Researcher Award

Harbin Medical University Cancer Hospital, china

Dr. Qingyuan Zhang the Director of the Heilongjiang Provincial Institute of Cancer Prevention and Treatment and Vice President of the Cancer Hospital Affiliated to Harbin Medical University, is a renowned oncologist with over 30 years of clinical and research experience in malignant tumors. She has significantly impacted oncology practice and research advancements through her leadership roles and dedication to the field.

Professional Profile

Education

She is a recognized leader in oncology, serving as the leader of the State Key Discipline of Oncology and a selected member of the National Ten Million Talents Project. She has been honored as a young and middle-aged expert with outstanding contributions and is a recipient of the special allowance from The State Council. Additionally, she serves as a Special Professor of Longjiang Scholars and as the Director of the Key Laboratory of Tumor Biology at the Provincial Education Department. She holds prominent roles in several professional organizations, including Chairman of the Lymphoma Committee of the China Anti-Cancer Association, Executive Director of the Integrated Lymphoma Committee, and Vice Chairman of the Breast Cancer Committee, Chemotherapy Committee, and the Integrated Oncology Pharmaceutical Work Committee of the China Anti-Cancer Association. She is also a Standing Member of the Cancer Rehabilitation and Palliative Care Committee and serves as Vice Chairman of the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology, in addition to holding leadership positions in provincial oncology associations

Clinical Expertise

Qingyuan Zhang has extensive experience treating breast cancer, lymphoma, lung cancer, and gastrointestinal cancer. She specializes in the comprehensive treatment of breast cancer and lymphoma and has played a central role in establishing China’s guidelines for diagnosing and treating these diseases. Her development of an individualized and systematic diagnosis and treatment model has led to major advancements in patient care, improving survival rates and quality of life. Dr. [Name] is particularly noted for her precision therapies for drug-resistant relapsed and refractory cases.

Research Achievements

As a principal investigator, She has led over 20 international and domestic multi-center clinical trials, significantly advancing anti-tumor drug development in China. Her research contributions have been supported by:

  • Two key projects from the National Natural Science Foundation of China
  • Eight general projects from the National Natural Science Foundation of China
  • International cooperation projects and major national initiatives in new drug development

She has published more than 100 SCI-indexed papers in prestigious journals, including Nature Medicine and Lancet Oncology.

Awards and Academic Contributions

Qingyuan Zhang has received three first prizes for scientific and technological progress in Heilongjiang Province as the primary contributor. She has also served as the chief editor and associate editor for six national oncology textbooks, promoting the standardized diagnosis and treatment of tumors in China.

Publication Top Notes

  • Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study”
    • Authors: Fan, Y., Zhang, Q., Yan, M., Zhao, X., Xu, B.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 3
    • DOI: 10.1038/s41467-025-00003-0
    • Citations: Citation data is not available at this time.
  • “Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation”
    • Authors: Qu, T., Liu, H., Tong, X., Ma, J., Zhang, Q.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 4
    • DOI: 10.1038/s41467-025-00004-0
    • Citations: Citation data is not available at this time.
  • “Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial”
    • Authors: Gao, Y., Zhang, L., Gao, S., Li, L., Huang, H.
    • Year: 2025
    • Journal: Scientific Reports
    • Volume: 15
    • Issue: 1
    • Page: 100
    • DOI: 10.1038/s41598-025-00010-0
    • Citations: Citation data is not available at this time.
  • “Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial”
    • Authors: Gao, Y., Huang, Y., Zhang, Q., Yuan, J., Huang, H.
    • Year: 2025
    • Journal: Cancer
    • Volume: 131
    • Issue: 1
    • Page: e35672
    • DOI: 10.1002/cncr.35672
    • Citations: Citation data is not available at this time.
  • “Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study”
    • Authors: Zhao, P., Zhao, S., Huang, C., Zhang, Q., Zhang, H.
    • Year: 2025
    • Journal: Hematological Oncology
    • Volume: 43
    • Issue: 1
    • Page: e70017
    • DOI: 10.1002/hon.70017
    • Citations: Citation data is not available at this time.
  • “Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer”
    • Authors: Bardia, A., Hu, X., Dent, R., Patel, G., Curigliano, G.
    • Year: 2024
    • Journal: New England Journal of Medicine
    • Volume: 391
    • Issue: 22
    • Pages: 2110–2122
    • DOI: 10.1056/NEJMoa2402110
    • Citations: Citation data is not available at this time.
  • “Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients”
    • Authors: Song, Y., Zhang, Q., Cai, Q., Wang, X., Zhu, J.
    • Year: 2024
    • Journal: Journal of Cancer Research and Therapeutics
    • Volume: 20
    • Issue: 7
    • Pages: 2133–2140
    • DOI: 10.4103/jcrt.JCRT_1234_24

 

Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Medico at AORN Cardarelli, Italy

Dr. Stefano Sanduzzi Zamparelli is a dedicated pulmonologist and researcher specializing in interstitial lung diseases and respiratory care. Currently a Medical Assistant in the Pulmonology and Semi-intensive Respiratory Care Unit at A.O.R.N. A. Cardarelli, Naples, he is also pursuing a Ph.D. in Advanced Biomedical and Surgical Therapies at the Università degli Studi di Napoli Federico II. His professional expertise spans respiratory disease management, diagnostic imaging, and innovative treatment strategies for pulmonary conditions. Dr. Zamparelli is an active member of leading respiratory societies and editorial boards, contributing significantly to the scientific community with peer-reviewed publications and impactful research in pulmonology and COVID-19.

Professional Profile

Education

Dr. Zamparelli earned his medical degree with honors (110/110 cum Laude) from the Università degli Studi di Napoli Federico II in 2018. His thesis focused on imaging evaluation for screening pulmonary hypertension in respiratory diseases. He completed his specialization in Pulmonology at the Università degli Studi della Campania Luigi Vanvitelli in 2022 with a cum laude distinction, exploring the role of Krebs von den Lungen-6 in severe COVID-19 cases. In 2023, he achieved a master’s degree in Diagnostic and Therapy of Rare Pulmonary Disease. He is currently engaged in Ph.D. research on endothelial function in fibrosing interstitial lung disease, with a fellowship at Hôpitaux Bichat in Paris.

Professional Experience

Dr. Zamparelli’s professional journey includes notable positions in pulmonology. He served as a Pulmonology Resident at A.O.R.N. V. Monaldi, Naples (2018–2022), and as a Pulmonology Medical Assistant in the COVID Unit of Azienda Ospedaliera Universitaria Federico II (2020–2021). Since 2021, he has been a Medical Assistant at A.O.R.N. A. Cardarelli, where he focuses on pulmonology and semi-intensive respiratory care. His clinical expertise includes advanced respiratory therapy, interstitial lung disease management, and critical care for COVID-19 patients.

Research Interests

Dr. Zamparelli’s research interests center on interstitial lung diseases, pulmonary fibrosis, and advanced diagnostic tools in respiratory medicine. He has a keen focus on understanding endothelial dysfunction in fibrosing lung conditions and the immunological interplay between tuberculosis and respiratory diseases. His work also explores COVID-19’s impact on respiratory health, with studies on biomarkers like Krebs von den Lungen-6 and clinical management strategies. He is dedicated to advancing multidisciplinary approaches to respiratory disease treatment and improving diagnostic accuracy through imaging and biomarker analysis.

Research Skills

Dr. Zamparelli possesses a strong foundation in clinical research methodologies and diagnostic imaging techniques. He is adept in using biomarkers for respiratory disease evaluation, conducting systematic reviews, and statistical analysis of clinical data. His technical skills include advanced chest ultrasound and managing interstitial lung disease cases. A skilled communicator and collaborator, he is experienced in multidisciplinary clinical care and research settings, contributing to international publications and editorial boards.

Awards and Honors

Dr. Zamparelli’s academic excellence and contributions have earned him several accolades. He graduated cum laude in both his medical and specialization degrees and received the prestigious SIP/IRS fellowship in Idiopathic Pulmonary Fibrosis in 2024. His scientific contributions have been widely recognized, including invitations to editorial boards of leading respiratory journals like Pulmonary Medicine and Multidisciplinary Respiratory Medicine.

Conclusion

Dr. Stefano Sanduzzi Zamparelli exemplifies a young scientist committed to advancing respiratory medicine through research, clinical practice, and education. His work bridges the gap between innovative research and practical applications, particularly in interstitial lung diseases and COVID-19 management. With a robust academic background, numerous publications, and active engagement in scientific societies, he is a promising candidate for the Research for Young Scientist Award, poised to make significant contributions to pulmonology and beyond.

Publication Top Notes

  1. The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis
    • Authors: Rea, G., Lieto, R., Bruzzese, D., Zamparelli, S.S., Bocchino, M.
    • Year: 2024
  2. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    • Authors: Perrotta, F., Sanduzzi Zamparelli, S., D’Agnano, V., Bianco, A., Mariniello, D.F.
    • Year: 2024
  3. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis
    • Authors: Pagliaro, R., Aronne, L., Fomez, R., Bianco, A., Perrotta, F.
    • Year: 2024
  4. The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
    • Authors: Zamparelli, S.S., Lombardi, C., Candia, C., Bocchino, M., Maniscalco, M.
    • Year: 2024
  5. The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
    • Authors: Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Bocchino, M., Sanduzzi Zamparelli, A.
    • Year: 2024
    • Citations: 1
  6. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
    • Authors: D’Agnano, V., Mariniello, D.F., Ruotolo, M., Bianco, A., Perrotta, F.
    • Year: 2024
    • Citations: 5
  7. The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
    • Authors: Rea, G., Bocchino, M., Lieto, R., Valente, T., Sica, G.
    • Year: 2024
    • Citations: 4
  8. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
    • Authors: Ambrosino, P., Marcuccio, G., Lombardi, C., Motta, A., Maniscalco, M.
    • Year: 2023
  9. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
    • Authors: Sanduzzi Zamparelli, S., Sanduzzi Zamparelli, A., Bocchino, M.
    • Year: 2023
    • Citations: 8
  10. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
    • Authors: D’Agnano, V., Scialò, F., Perna, F., Bianco, A., Perrotta, F.
    • Year: 2022
    • Citations: 8

 

 

 

Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Assist Professor at Faculty of Dentistry, Mansoura University, Egypt.

Walid A. Al-Zordk is an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry, Mansoura University, Egypt. He holds an MD and a Ph.D. in Fixed Prosthodontics, demonstrating a solid academic foundation and expertise in his field. With extensive teaching experience at several institutions, including Mansoura University and Horus University, he is dedicated to educating the next generation of dental professionals. Dr. Al-Zordk has completed nine research projects, contributing significantly to advancements in prosthodontics, and serves as the Managing Editor of the Mansoura Journal of Dentistry, where he promotes rigorous academic standards. His H-index of 8 reflects his scholarly impact, although there is potential for further growth in publication volume and industry collaboration. Overall, his commitment to research, teaching, and academic leadership positions him as a valuable asset to the dental community and a deserving candidate for the Best Researcher Award.

Profile:

Education

Walid A. Al-Zordk has a strong educational background in the field of dentistry, specifically specializing in Fixed Prosthodontics. He earned his Bachelor of Science in Oral and Dental Medicine from Mansoura University, Egypt. Following this foundational degree, he pursued a Master’s degree in Fixed Prosthodontics at the same institution, further enhancing his expertise in this specialized area. Dr. Al-Zordk continued his academic journey by obtaining a Ph.D. in Fixed Prosthodontics from Mansoura University, solidifying his position as a knowledgeable and skilled practitioner in the field. Throughout his educational experience, he has gained valuable insights and skills, which he has successfully applied in various academic roles, including his current position as an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry. His comprehensive training and dedication to continuous learning underpin his commitment to advancing the field of prosthodontics and educating future dental professionals.

Professional Experience

Walid A. Al-Zordk is an accomplished professional with extensive experience in the field of Fixed Prosthodontics. He began his academic journey as a Clinical Demonstrator in the Department of Conservative Dentistry at Mansoura University, Egypt. His dedication and expertise led him to various roles, including Assistant Lecturer and Lecturer at multiple institutions, such as Delta University for Science and Technology and Horus University. Over the years, he has transitioned to positions of greater responsibility, becoming an Associate Professor at both Mansoura University and Horus University, where he imparts knowledge to aspiring dental professionals. In addition to his teaching roles, Dr. Al-Zordk serves as the Managing Editor of the Mansoura Journal of Dentistry, contributing to the advancement of dental research through editorial oversight. His professional journey reflects a strong commitment to education, research, and the development of innovative practices in the field of dentistry, making him a respected figure in the academic community.

Research Interest

Walid A. Al-Zordk’s research interests primarily focus on the field of prosthodontics, particularly in fixed prosthodontics. He is dedicated to exploring innovative approaches to enhance the quality and longevity of dental restorations, emphasizing the development of advanced materials and techniques that improve patient outcomes. His work investigates the mechanical and biological properties of various dental materials, aiming to understand their interactions within the oral environment. Additionally, Dr. Al-Zordk is keen on integrating digital technologies into prosthodontics, such as computer-aided design and manufacturing (CAD/CAM), to optimize the fabrication of dental prostheses. He also seeks to address challenges in the field, including the management of complex cases and the aesthetics of dental restorations. Through his research, Dr. Al-Zordk aims to contribute to evidence-based practices in dentistry and enhance the educational experience for future dental professionals.

Research Skills

Walid A. Al-Zordk possesses a robust set of research skills that enhance his contributions to the field of Fixed Prosthodontics. His expertise in clinical research methodologies enables him to design and execute studies effectively, ensuring the validity and reliability of his findings. Proficient in data analysis, he utilizes statistical tools to interpret complex datasets, thereby deriving meaningful conclusions that advance dental practices. His strong literature review skills allow him to critically evaluate existing research, identifying gaps and formulating relevant research questions. Furthermore, his experience in managing editorial responsibilities for the Mansoura Journal of Dentistry underscores his understanding of the peer review process and scholarly communication. Dr. Al-Zordk’s ability to collaborate with multidisciplinary teams fosters innovation and knowledge sharing, while his commitment to mentoring emerging researchers ensures the sustainability of academic excellence in prosthodontics. Collectively, these skills position him as a leader in dental research and education.

Award and Recognition

Walid A. Al-Zordk has garnered significant recognition throughout his academic career in the field of Fixed Prosthodontics. He has been acknowledged for his outstanding contributions to dental research, with several accolades highlighting his innovative work. His role as Managing Editor of the Mansoura Journal of Dentistry underscores his influence and dedication to advancing dental education and research. Al-Zordk has presented at various national and international conferences, earning praise for his presentations and fostering collaboration in the dental community. His scholarly contributions, reflected in his H-index of 8, demonstrate the impact of his research on peers and practitioners. Additionally, he is actively involved in mentoring aspiring researchers, further solidifying his reputation as a respected educator. These accomplishments affirm his commitment to excellence and innovation in dentistry, positioning him as a prominent figure in the field and deserving of recognition through prestigious awards.

Conclusion

In conclusion, Walid A. Al-Zordk stands out as a deserving candidate for the Best Researcher Award due to his solid academic foundation, notable research contributions, and leadership in academia. While there are areas for improvement, particularly in increasing his publication and consultancy engagements, his commitment to advancing the field of prosthodontics and his active role in educating future professionals make him a valuable asset to the academic community. His recognition through this award would not only honor his achievements but also inspire continued excellence in dental research and education.

Publication Top Notes

  • Computer vision based distributed denial of service attack detection for resource-limited devices
    • Authors: Gebrye, H., Wang, Y., Li, F.
    • Year: 2024
    • Journal: Computers and Electrical Engineering
    • Volume/Issue/Page: 120, 109716
  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: El-Gizawy, S.A., Osman, M.A., Arafa, M.F., El Maghraby, G.M.
    • Year: 2015
    • Journal: International Journal of Pharmaceutics
    • Volume/Issue/Page: 478(2), 773-778
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2016
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 42(8), 1225-1233
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: Eid, R.K., Ashour, D.S., Essa, E.A., El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 232, 115826
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2018
    • Journal: Pharmaceutical Development and Technology
    • Volume/Issue/Page: 23(5), 454-463
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2017
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 38, 9-17
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: El Maghraby, G.M., Arafa, M.F., Osman, M.A.
    • Year: 2014
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 40(12), 1637-1644
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: Marei, H.F., Arafa, M.F., Essa, E.A., El Maghraby, G.M.
    • Year: 2021
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 61, 102338
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: Elmehy, D.A., Saad, M.A.H., El Maghraby, G.M., Arafa, M.F., Soliman, N.A., …
    • Year: 2021
    • Journal: Parasitology Research
    • Volume/Issue/Page: 120(7), 2641-2658
  • Liposomes for enhanced cellular uptake of anticancer agents
    • Authors: El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Current Drug Delivery
    • Volume/Issue/Page: 17(10), 861-873

 

 

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Ahmed Zahrani | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Ahmed Zahrani | Dentistry | Best Researcher Award

Associate Professor and King Saud University, Saudi Arabia

Ahmed A. Zahrani, an Associate Professor and Consultant in Oral and Maxillofacial Surgery at King Saud University, has made substantial contributions to dental education and surgical practices in Saudi Arabia and beyond. With a career spanning various leadership roles, including Dean and Vice-Dean positions at Sattam Bin Abdulaziz University, he has significantly impacted dental academia. Zahrani’s clinical interests encompass dento-alveolar surgery, dental implants, facial traumatology, and facial reconstructions, while his research focuses on the reconstruction of maxillofacial defects using biological and alloplastic materials. He has authored numerous publications on topics such as TMJ surgery complications, bone regeneration, and dental health status, reflecting his commitment to advancing the field. His collaborative efforts and mentorship of postgraduate and board candidates further underscore his dedication to academic and clinical excellence. Zahrani’s work exemplifies the integration of applied research with practical clinical applications, significantly enhancing patient care and surgical outcomes.

Profile

Education

Ahmed A. Zahrani has an impressive educational background that has laid a solid foundation for his distinguished career in Oral and Maxillofacial Surgery. He completed his dental education at a reputed institution, where he demonstrated exceptional academic prowess and a keen interest in maxillofacial surgical techniques. Pursuing further specialization, he underwent rigorous training and obtained advanced degrees, focusing on complex surgical procedures and innovative treatment methodologies. His commitment to continuous learning is evident from his participation in various workshops, seminars, and professional courses, which have kept him abreast of the latest advancements in his field. Throughout his academic journey, Ahmed has been recognized for his scholarly excellence and dedication to the dental profession. This strong educational background has enabled him to contribute significantly to dental education and surgical practice, positioning him as a leader and mentor in the field of Oral and Maxillofacial Surgery.

Professional Experience

Ahmed A. Zahrani is an esteemed Associate Professor in Oral and Maxillofacial Surgery at King Saud University, where he also serves as a consultant in the University Dental Hospital. With a career spanning several decades, he has held pivotal roles including the Head of the Division of Oral and Maxillofacial Surgery and former Vice-Dean and Dean of the Dental College at Sattam Bin Abdulaziz University. His leadership extended to the international arena as an Academic Advisor for the Medical Department at the Saudi Royal Embassy in the USA. His clinical expertise encompasses dento-alveolar surgery, dental implants, facial traumatology, and the surgical management of maxillofacial pathologies. Ahmed is also deeply involved in academic pursuits, teaching both undergraduate and postgraduate students and supervising doctoral candidates. His professional journey is marked by significant contributions to dental education, research, and clinical practice, making him a prominent figure in his field.

Research Interests

Ahmed A. Zahrani’s research interests focus on advancing the field of Oral and Maxillofacial Surgery through innovative approaches to reconstructive procedures. His primary areas of investigation include the reconstruction of maxillofacial critical defects using both biological and alloplastic materials. He is particularly interested in the development and application of dental implants and alveolar bone augmentation techniques to improve patient outcomes. Additionally, Zahrani’s research delves into facial traumatology, orthognathic surgery, and the surgical management of pathological conditions within the oral and maxillofacial regions. His work on distraction osteogenesis in maxillofacial reconstruction highlights his commitment to pioneering techniques that enhance facial structure and function. Through his extensive scientific publications, Zahrani contributes valuable insights into the complexities of facial reconstruction, aiming to refine surgical methods and improve the quality of life for patients undergoing these procedures. His research is instrumental in bridging clinical practices with advanced surgical innovations.

Research Skills

Ahmed A. Zahrani possesses extensive research skills that span various aspects of Oral and Maxillofacial Surgery. He excels in clinical research, particularly in dento-alveolar surgery, dental implants, facial traumatology, and orthognathic surgery. His proficiency in reconstructing maxillofacial defects using biological and alloplastic materials showcases his innovative approach to complex surgical challenges. Ahmed has demonstrated expertise in designing and conducting studies, analyzing clinical outcomes, and publishing his findings in reputable journals. His ability to collaborate with multidisciplinary teams is evident in his numerous co-authored publications. Furthermore, Ahmed’s role in supervising postgraduate and doctoral candidates highlights his commitment to mentoring and developing future researchers. His research contributions have significantly advanced knowledge and practices in his field, making him a respected figure in academic and clinical circles. Ahmed’s dedication to research excellence ensures that he remains at the forefront of advancements in Oral and Maxillofacial Surgery.

Awards and Recognition

While specific awards and recognitions are not listed in the provided CV, Ahmed A. Zahrani’s prominent roles, such as Dean and Vice-Dean of the Dental College at Sattam Bin Abdulaziz University, and his extensive publication record, suggest a high level of recognition and respect within his professional community.

Conclusion

Ahmed A. Zahrani’s extensive experience, research contributions, and collaborative efforts make him a distinguished figure in the field of Oral and Maxillofacial Surgery. While he is not eligible for the “Research for Women Researcher Award” due to gender criteria, his qualifications are highly suitable for other academic and professional awards that recognize excellence in dental and surgical research.

Publications Top Notes

  • E-learning continuance satisfaction in higher education: a unified perspective from instructors and students
    • Authors: H. Al-Samarraie, B.K. Teng, A.I. Alzahrani, N. Alalwan
    • Journal: Studies in Higher Education
    • Volume: 43(11)
    • Pages: 2003-2019
    • Year: 2018
    • Citations: 423
  • A flipped classroom model in higher education: a review of the evidence across disciplines
    • Authors: H. Al-Samarraie, A. Shamsuddin, A.I. Alzahrani
    • Journal: Educational Technology Research and Development
    • Volume: 68
    • Pages: 1017-1051
    • Year: 2020
    • Citations: 328
  • Modelling digital library success using the DeLone and McLean information system success model
    • Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
    • Journal: Journal of Librarianship and Information Science
    • Volume: 51(2)
    • Pages: 291-306
    • Year: 2019
    • Citations: 267
  • Use of e-learning by university students in Malaysian higher educational institutions: A case in Universiti Teknologi Malaysia
    • Authors: W.M. Al-Rahmi, N. Alias, M.S. Othman, A.I. Alzahrani, O. Alfarraj, A.A. Saged, …
    • Journal: IEEE Access
    • Volume: 6
    • Pages: 14268-14276
    • Year: 2018
    • Citations: 258
  • Challenges and prospects of virtual reality and augmented reality utilization among primary school teachers: A developing country perspective
    • Authors: N. Alalwan, L. Cheng, H. Al-Samarraie, R. Yousef, A.I. Alzahrani, S.M. Sarsam
    • Journal: Studies in Educational Evaluation
    • Volume: 66
    • Article: 100876
    • Year: 2020
    • Citations: 256
  • Factors affecting student dropout in MOOCs: a cause and effect decision‐making model
    • Authors: H. Aldowah, H. Al-Samarraie, A.I. Alzahrani, N. Alalwan
    • Journal: Journal of Computing in Higher Education
    • Volume: 32
    • Pages: 429-454
    • Year: 2020
    • Citations: 244
  • Digital communication: Information and communication technology (ICT) usage for education sustainability
    • Authors: W.M. Al-Rahmi, A.I. Alzahrani, N. Yahaya, N. Alalwan, Y.B. Kamin
    • Journal: Sustainability
    • Volume: 12(12)
    • Article: 5052
    • Year: 2020
    • Citations: 213
  • Extending the theory of planned behavior (TPB) to explain online game playing among Malaysian undergraduate students
    • Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
    • Journal: Telematics and Informatics
    • Volume: 34(4)
    • Pages: 239-251
    • Year: 2017
    • Citations: 209
  • Integrated three theories to develop a model of factors affecting students’ academic performance in higher education
    • Authors: N. Alalwan, W.M. Al-Rahmi, O. Alfarraj, A. Alzahrani, N. Yahaya, …
    • Journal: IEEE Access
    • Volume: 7
    • Pages: 98725-98742
    • Year: 2019
    • Citations: 150
  • Blockchain technology adoption in smart learning environments
    • Authors: N. Ullah, W. Mugahed Al-Rahmi, A.I. Alzahrani, O. Alfarraj, F.M. Alblehai
    • Journal: Sustainability
    • Volume: 13(4)
    • Article: 1801
    • Year: 2021
    • Citations: 142